MXM Stats & Data
COc1cccc(c1)C1(NC)CCCCC1=OZGQWDAOLJNAADS-UHFFFAOYSA-NReceptor Profile
Receptor Actions
Effect Profile
Curated + 1 ReportsStrong dissociative depth and motor impairment with mild mania, low insight
Duration Timeline
BluelightTolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Tolerance appears to increase rapidly after one strong session and decays over 1–2+ weeks, consistent with other arylcyclohexylamines; values are heuristic from user reports, not formal studies.
Cross-Tolerances
Experience Report Analysis
ErowidDemographics
Gender Distribution
Age Distribution
Reports Over Time
Harm Reduction
drugs.wiki- Naming and supply: MXM is widely discussed as 'Methoxmetamine' or simply 'MXM'; it has also been sold under confusing vendor labels like 'e-Methoxetamine'. Confusion with MXE and other 2-oxo arylcyclohexylamines has occurred; identity verification via reagent tests and, where available, GC/MS drug checking is strongly advised. In some markets, ketamine samples have been found to actually contain other arylcyclohexylamines (e.g., MXE), underscoring the value of checking.
- ROA efficiency: Early reports consistently describe poor nasal efficacy and irritation with MXM; oral/sublingual routes produce more reliable effects for most users at comparable or lower totals.
- Onset/plateau: Compared to MXE, MXM typically comes on faster and runs shorter (often ~2–3 h), which can encourage compulsive redosing—pre-weigh doses and set a firm maximum before starting.
- Tolerance: Dissociative tolerance rises quickly, sometimes after a single strong session, and cross-tolerance with ketamine/MXE/other arylcyclohexylamines is expected. Allow long breaks (≥2 weeks) between sessions to reduce escalation.
- Bladder/urinary risk: Like other dissociatives, repeated/frequent use is associated with urinary tract problems (urgency, frequency, pain). Stop use and seek medical evaluation if symptoms appear; spacing sessions and maintaining hydration may reduce risk.
- Mental health: MXM can produce agitation or hypomanic qualities in some users; avoid if you have a history of psychosis or bipolar disorder, and do not combine with stimulants during/after high doses. Ensure a safe environment and sober support if experimenting with unfamiliar doses.
- IM-specific HR: If choosing IM, use new sterile equipment, sterile water, proper site cleaning (single swipe with alcohol swab, let dry), rotate sites, and consider a 0.22–0.30 µm filter to reduce insoluble particles/endotoxin. Avoid IV due to very rapid onset and loss of motor control.
- Driving and hazards: Severe impairment of coordination, balance and situational awareness occurs; plan not to drive or operate machinery for at least 24 hours after use.
- Volumetric dosing and scales: Because redosing and impaired judgment are common on dissociatives, pre-measure doses with a 0.001 g scale; volumetric solutions can improve accuracy and reduce accidental heavy intakes.
References
Data Sources
Cited References
- Big & Dandy Methoxmetamine thread – Bluelight forum (dose reports)
- Designer drugs review: mechanism & adverse effects (Springer 2019)
- Kaizaki-Mitsumoto et al., Phencyclidine analog MMXE forensic identification (Forensic Toxicology 2015)
- List of designer drugs – arylcyclohexylamine section
- MedChemExpress: datasheet – Methoxmetamine hydrochloride
- PsychonautWiki: Dissociatives
- SAR analysis: methoxetamine & PCP analogues NMDA affinity (PLOS ONE 2013)
- TrippyWiki: MXM overview & duration
- X-ray powder diffraction data for methoxmetamine HCl (Powder Diffraction 2018)
- Bluelight: user ‘blueberries’ rapid-tolerance notes (post #10)
Drugs.wiki References
- ☛ Official ☚ The Big & Dandy Methoxmetamine / MXM Thread (naming, early dosing, ROA) – Bluelight
- Bluelight MXM thread, p1–3 (oral/insufflated trials; compulsion, short duration; manic qualities)
- TripSit Drug Combinations – MXE & MDMA, stimulants, alcohol/benzos cautions (extrapolated to MXM)
- Hi‑Ground Ketamine page – dissociative HR (urinary risk, combo cautions, injecting HR, driving)
- Toronto Drug Checking Service – program overview (why to use lab testing)
- Saferparty Zürich alert – MXE sold as ‘ketamine’ (illustrates arylcyclohexylamine mislabel risk)
- TripSit Volumetric Converter (practical tool for accurate dosing)